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Abstract Depressive symptoms occurring late in life are an
important risk factor for Alzheimer’s disease (AD). The
latest research finds that onset of depressive symptoms in
late life may herald the development of AD, not only for
amnestic Mild Cognitive Impairment (aMCI) patients, but
also for cognitively-normal older adults. Neuroimaging of
brain structure, blood flow, and glucose metabolism
indicates that depressive symptoms in late life are accom-
panied by structural and functional changes in limbic brain
regions vulnerable to AD. The present cross-sectional study
was guided by the hypothesis that compared to their non-
depressed counterparts, older adults with mild to moderate
depressive symptoms have less volume in limbic structures
vulnerable to changes in AD—specifically, cortical midline
structures such as anterior cingulate and posterior cingulate
cortex as well as mesial temporal regions such as bilateral
hippocampi and amygdalae. Consistent with our hypothe-
sis, results of a voxel-based morphometry analysis revealed
smaller retrosplenial, posterior cingulate, and precuneus
gray matter volumes in depressed individuals relative to
healthy controls. Right lateral parietal cortex—another
region vulnerable to change in AD—was also smaller in
the group with depressive symptoms. Contrary to our
hypothesis, no volumetric differences were found in the
anterior cingulate cortex or mesial temporal lobe. Results of
this study show a relationship between geriatric depressive
symptoms and brain volume in regions vulnerable to AD.
Follow-up of participants over time will tell if brain
changes detected here predict development of AD.
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With the expected upsurge in the incidence and prevalence
of Alzheimer’s disease (AD) in coming decades, increasing
research attention focuses on early detection (Fagan et al.
2005; Mueller et al. 2005; Sager et al. 2005). A handful of
important AD risk factors are known—including specific
genotypes such as homo- or heterozygosity for the
apolipoprotein 4 (APOε4) allele, family history of AD,
and amnestic mild cognitive impairment (aMCI)—a condi-
tion in which one shows impaired memory but intact
functional abilities. Depressive symptoms occurring late in
life are also an important risk factor. In fact, some reports
suggest that affective changes may be the earliest symptoms
of AD pathology in some individuals—even predating the
cognitive decline that portends development of AD (Geda
et al. 2006; Stepaniuk et al. 2008).
Neuropsychiatric symptoms are more prevalent in AD
than in the rest of the elderly population, with 35–75% of
AD patients showing depressive symptoms, apathy, anxiety,
or increased irritability (see Apostolova and Cummings
2008 for review). Prevalence estimates of neuropsychiatric
symptoms vary with the source of the study sample, the
sensitivity of the neuropsychiatric measure used, and the
use of a formal psychiatric interview versus symptom
questionnaire—yet depressive symptoms and apathy are
consistently the most common neuropsychiatric symptoms
in mild AD. (In our discussion of the literature, a formal
diagnosis of Major Depressive Disorder ascertained by a
structured psychiatric interview will be indicated as MDD;
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“depression” or depressive symptoms.) Individuals with
aMCI show a high prevalence MDD, and presence of MDD
in aMCI introduces a 2.6-fold increase for developing AD
over the next three years (Modrego and Ferrandez 2004).
Furthermore, depressive symptoms shown by many aMCI
patients who progress to AD is refractory to anti-depressant
medications (Li et al. 2001).
Symptoms in many depressed older patients who later
develop AD may have a different etiology than depressive
symptoms in younger adults—this etiology may be AD
pathology or a factor mediating the association between
depression and AD. AD with comorbid depressive symptoms
is associated with greater cortical neurofibrillary tangle
development than AD alone (Rapp et al. 2008). Also, studies
of late-life depression that control for anti-depressant use and
cardiovascular risk found that compared to non-depressed
older adults, their depressed counterparts have lower plasma
Aβ42 levels and higher Aβ40:Aβ42 ratios—a profile similar to
that seen in many early AD patients (Qiu et al. 2007;S u ne t
al. 2008). Additionally, recent research finds that onset of
depressive symptoms in late life may herald the development
of AD, not only for aMCI patients, but also for cognitively-
normal older adults (Geda et al. 2006; Stepaniuk et al. 2008).
Taken together, these new data suggest that in some older
adults, late-onset depression is an early behavioral sign of AD.
Neuroimaging of brain structure, blood flow, and
glucose metabolism indicates that depressive symptoms in
late life relate to structural and functional changes in limbic
brain regions vulnerable to AD. Volumetric studies using
region of interest (ROI) analyses show that older adults
with depressive symptoms show reduced hippocampal,
anterior cingulate, and orbitofrontal volumes compared to
non-depressed controls (Ballmaier et al. 2004;B e l l -
McGinty et al. 2002; Drevets et al. 1997); however, these
findings are not unequivocal (Kumar et al. 2006). Anterior
and posterior cingulate cortex and the amygdala also show
abnormal glucose metabolism and blood flow in MDD
(Bench et al. 1992; Drevets 1999; Drevets et al. 1997).
The numerous ROI volumetric brain studies cited above
have advanced our understanding of brain volume changes—
particularly hippocampal changes—in late-life depression.
However,muchistobelearnedaboutthewider-rangeofbrain
changes occurring in geriatric depression. Changes in brain
structures that have less clearly defined boundaries are
difficult to quantify with ROI analysis, and for this reason
these brain regions are not typically studied via ROI methods.
In contrast to region-specific analyses, voxel-based mor-
phometry (VBM) provides a comprehensive assessment of
anatomical differences throughout the brain, avoiding possi-
ble bias inherent in investigating volume differences within
only selected brain structures.
The aim of the current cross-sectional VBM study is to
investigate volumetric differences of limbic brain regions in
healthy elderly adults with and without depressive symp-
toms. Many studies cited above have investigated symp-
toms of major depressive disorder; however, others have
found that subclinical depressive symptoms are also
prognostic of MCI and AD. We hypothesized that older
adults with depressive symptoms have less volume in
limbic structures vulnerable to changes in AD, specifically
cortical midline structures such as anterior cingulate and
posterior cingulate cortex as well as mesial temporal
regions such as bilateral hippocampi and amygdalae.
Methods
Participants
Forty-seven cognitively-healthy elderly individuals in
the Madison community who responded to newspaper
advertisements and mass e-mails to the University of
Wisconsin-Madison community for studies on aging and
cognition participated in this study. Participants whose
data are included in this manuscript were recruited as
cognitively-healthy control participants. At entry into
this study, subjects were asked if they had a history of
or current Major Depression that required treatment.
Indicating a positive history for treated Major Depres-
sion was exclusionary for this study. Depressive symp-
toms were measured via the Center for Epidemiologic
Studies Depression (Radloff 1977; CES-D). The CES-D
includes twenty items rating somatic, evaluative, mood,
and motivational symptoms of depression experienced
within the past week. Symptoms targeted by each item are
rated on a four-point frequency scale (i.e., rarely/none, some/
little, occasionally/moderate, most/ all of the time). Items
on the CES-D load onto four factors: depressed affect,
positive affect, somatic symptoms/retarded activity, and
interpersonal activity. Fifteen participants comprising a
“depressed” group endorsed mild to moderate depressive
symptoms as measured by the CES-D (score ≥ 10). None
of the participants were being treated for major depressive
disorder or had a history of major depressive disorder
according to their self-report. This group with depressive
symptoms is labeled the “depressed group” in this paper.
Thirty-two participants comprising a control group en-
dorsed no or minimal symptoms of depression (score ≤ 5).
The two groups were similar in age, gender distribution,
and performance on several neuropsychological tests (see
Table 1). The control group had significantly more
education than the depressed group. Therefore, this
variable was included as a covariate within the statistical
model.
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for both groups included cognitive disorders such as mild
cognitive impairment (MCI) or AD, a history of traumatic
brain injury defined by traumatically induced loss of
consciousness for greater than ten minutes, diagnosis of
other neurological disorder including multi-infarct demen-
tia, alcohol and drug abuse or dependence, Hachinski
Ischemia Scale ≤ 4, hypertension with persistent blood
pressure recordings on at least three occasions of diastolic >
100; systolic > 160, MRI incompatibility, diagnosis of
major medical disorders including cancer within five years
of the study, and participant report of current or prior
diagnosis of any psychiatric disorder, including major
depressive disorder. Exclusion criteria also included evi-
dence of focal lesions, multiple lacunes, or at least one
lacune in a critical memory structure on the T1-weighted
MRI scan. All subjects provided written informed consent
before participating in this local IRB approved study.
Subjects were recruited from the community by advertise-
ment, mailings, and community outreach events.
Neuropsychological assessment
The participants completed a cognitive battery (Table 1)
using standardized administration procedures (Spreen and
Strauss 1998). The battery examined a variety of functions
including verbal and visuospatial learning, memory recall
and recognition, and executive functions. There were no
significant differences between groups in any of these
cognitive measures.
Imaging protocol
Participants were situated on the bed of a GE long bore 3.0
Tesla MRI scanner (General Electric, Milwaukee, WI).
Head movement was constrained by foam padding. A 3D
inversion recovery-prepared fast gradient echo pulse se-
quence provided high-resolution T1-weighted structural
images acquired in the axial plane with the following
parameters: inversion time = 600 ms, fast gradient echo
read-out with TR/TE/flip = 9 ms/1.8 ms/20°; acquisition
matrix = 256×192×124 (interpolated to 256×256×124);
field of view = 240 mm; slice thickness = 1.2 mm (124
slices); ± 16 kHz receiver bandwidth. A Fast Recovery Fast
Spin Echo 2D T2-weighted axial sequence was also
acquired with the same start and stop locations as the T1
weighted images. The parameters were: field of view =
240 mm, matrix 256×256, TR = 9,000 ms, TE = 93 ms,
flip angle = 90. Seventy slices were acquired; slice
thickness = 1.7 mm with 0.3 mm skip.
A neuroradiologist viewed the anatomical images from
each participant for clinically relevant brain abnormalities
inconsistent with control diagnosis or requiring clinical
follow-up. The T1-weighted images were then used for the
VBM analyses.
Voxel-based morphometry methods
The Voxel Based Morphometry (VBM) approach as
described by Good et al. (2001) was used to analyze the
T1 weighted anatomical images. Statistical Parametric
Mapping (SPM5) software was utilized to segment the
images into gray matter (GM), white matter (WM), and
cerebrospinal fluid (CSF) probability maps. A customized
GM template in the common MNI atlas space was created
using the T1 volumes of all subjects using methods
previously described (Trivedi et al. 2006). The individual
GM images were then normalized to this template and
smoothed to 12 mm.
Study design and statistical analysis
This was a cross-sectional study comparing the brain
volumes of participants with depressive symptoms to those
of participants without depressive symptoms. We used an
ANCOVA design with gender, education, and total intra-
cranial volume (TICV) as covariates. Due to the relatively
small sample sizes, and because our analyses were guided
by a priori hypotheses, between-group differences were
Table 1 Demographic and Neuropsychological Data for depressed
and non-depressed groups
Depressed (n=15) Non-depressed (n=32)
Age 66.3(5.3) 68.4(7.4)
Gender(M:F) 5:10 14:18
Education 14.6(2.4) 17.3(2.3)
CES-D
a 17.3(6.5) 1.8(1.8)
Trails A 30.1(7.4) 32.3(12.7)
Trails B 67.9(18.3) 71.5(26.1)
MMSE
b,g 29.0(1.0) 29.2(1.9)
RAVLT
c Total 47.0(8.1) 47.1(7.8)
RAVLT
c Delay Recall 9.3(2.6) 9.0(2.7)
BVMT
d Total 25.7(6.9) 24.7(7.0)
BVMT
d Delay Recall 9.4(2.4) 9.6(2.6)
COWAT
e,g 43.3(11.9) 47.0(11.8)
Animal Fluency
g 21.6(5.1) 20.7(4.3)
aCenter for Epidemiologic Studies Depression
bMini Mental State Examination
cRey Auditory Verbal Learning Test
dBrief Visuospatial Memory Test-Revised
eControlled Oral Word Associated Test
fAll indices of test performance are raw scores
gNumber of participants included in mean and standard deviation
calculations MMSE 14:32, COWAT 13:28, Animal Fluency 11:30
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p<.005, uncorrected).
Results
Behavioral data
There were no significant differences between the groups
on age or a series of cognitive tests (p>0.05) as
summarized in Table 1. Chi squared analysis revealed no
significant differences between the groups on gender
distribution. The depressed group had significantly fewer
years of education than the non-depressed group.
We examined the degree to which participants in the
depressed group endorsed items loading on the four factors
of the CES-D: depressed affect, positive affect, and somatic
symptoms/retarded activity, and interpersonal difficulty.
Results of a one-way repeated-measures ANOVA showed
significantly different levels of endorsement for the four
factors, F (3, 42) = 8.08, p<0.001. Post-hoc t-tests revealed
that participants in the depressed group endorsed signifi-
cantly fewer symptoms indicating interpersonal difficulty
than symptoms of depressed affect, t(14) = 4.13, p<.01,
positive affect, t(14) = 3.30, p<.01, or somatic symptoms/
retarded activity, t(14) = 3.67, p<.01. There were no
significant differences in endorsement of items loading on
depressed affect, positive affect, and somatic symptoms/
retarded activity factors.
Imaging data
The VBM analysis tested for group differences in the
presence of covariates for gender, education and TICV. The
analysis revealed lower gray matter volume in several
regions in depressed individuals relative to healthy controls,
as depicted in Fig. 1 and Table 2. These included
retrosplenial cortex, posterior cingulate cortex, precuneus
and lateral parietal areas. There were no volumetric differ-
ences in the mesial temporal lobe. Non-depressed partic-
ipants showed no areas of lower gray matter volume than
participants with depressive symptoms.
Discussion
Recent studies note a significant relationship between
depressive symptoms in older adults and increased risk for
AD. Therefore, the current study was guided by the
hypothesis that older adults with depressive symptoms
have less gray matter in cortical midline and mesial
temporal limbic regions known to be both associated with
affective self appraisal and vulnerable to changes in AD. To
test this hypothesis, we used a cross-sectional design to
assess gray matter volume differences between elderly
individuals with and without depressive symptoms.
Consistent with our hypothesis, results showed that older
adults with depressive symptoms (CES-D ≥ 10) had less
PCC volume compared with individuals without depressive
symptoms (CES-D ≤ 5). The PCC (Vogt et al. 2006)—a
region that shows some of the earliest metabolic, function-
al, and structural changes in individuals at risk for AD—is
part of a network of limbic brain structures involved in
memory (Buckner 2004; Morris et al. 2000; Shannon and
Buckner 2004), affect (Vogt et al. 2006), and self appraisal
(Johnson et al. 2002; Johnson et al. 2006; Northoff et al.
2006). Although the PCC is a limbic region, it is not
typically implicated in depressive symptoms of younger
adults. However, cognitive-affective appraisals commonly
Table 2 Results of two-group t-test: Non-depressed > Depressed
Region MNI coordinates Peak
T
value
kP
value
xyz
Lateral Parietal Cortex 32 −48 70 4.04 343 >0.001
28 −20 58 3.21 0.001
32 −36 60 3.37 0.001
Posterior Cingulate
Cortex/Retrosplenial
Cortex
2 −50 10 3.60 344 >0.001
−16 −50 26 3.11 0.002
−10 −54 30 2.90 0.003
16 −38 44 3.48 61 0.001
Lateral Parietal Cortex 38 −50 40 3.30 85 0.001
−8 −2 56 3.07 24 0.002
Fig. 1 Resultsofatwo-groupt-testrevealedthatthePCCandrightlateralparietalregionshadlessvolumeinthedepressedgroupthancontrols.Lateral
andTransversemaximumintensityprojections oftheentirewhole-brainmap arealsoshown.Therightsideofthebrainisontherightsideintheimages
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adults, and depression is characterized by altered self-
appraisal. People with depressive symptoms and MDD
show predominant negative self-appraisal—a bias indicated
by symptoms of worthlessness, pessimism and low self-
esteem, and/or they demonstrate apathy—a lack of affective
engagement that is necessary to make accurate self-
appraisals. Taken within this context, our results suggest
that although the PCC is not typically susceptible to
changes associated with depression in young adults,
changes to the PCC in older adults may constitute a
qualitatively-distinct etiology of depressive symptoms. The
fact that PCC structure and function is altered in AD and in
adults with high AD-risk suggests that this etiology may be
AD pathology.
We also found lower gray matter volume in the right
lateral parietal cortex of older adults with depressive
symptoms. Although this region was not included in our a
priori hypothesis, this region shows reliable functional
connectivity with the PCC (Greicius et al. 2003; Raichle et
al. 2001), and like the PCC, fMRI studies of memory and
self-appraisal consistently evoke activity in lateral parietal
regions (Northoff et al. 2006; Shannon and Buckner 2004).
Furthermore, lateral parietal structure and function is altered
in people with AD and those at risk for developing AD.
This supports our contention that AD-like changes may
underlie depressive symptoms in many older adults.
Because we chose to conduct whole-brain VBM
analysis, we detected parietal brain differences not
previously reported in ROI studies that have primarily
focused on the mesial temporal lobe. However, our
choice of analysis may not have been sensitive enough
to detect the hippocampal volume or morphologic
differences shown by other studies. Although evidence
for hippocampal volume loss in geriatric MDD and
depression generated from ROI volumetric studies is
m i x e d( A s h t a r ie ta l .1999; Greenwald et al. 1997;H i c k i e
et al. 2005;S t e f f e n se ta l .2000), detection of hippocampal
involvement in geriatric depression is seen more consis-
tently when using high resolution MR analysis of
hippocampal morphology. A recent study that selectively
assessed hippocampal morphology in cognitively-healthy
adults found changes specific to the subiculum and CA1
region in older adults with initial depressive symptom
development after age 60 (Ballmaier et al. 2008). In a
separate study, these same hippocampal regions—the
subiculum and CA1—showed morphologic alterations in
MCI patients who developed AD over a three-year period
(Apostolova et al. 2006). Our finding of PCC and lateral
parietal volume differences, taken with results of studies
targeting nuanced hippocampal changes, support the idea
that subtle AD-like changes underlie depressive symptoms
shown by some older adults.
Our failure to find volumetric group differences in the
anterior cingulate cortex was surprising, given that this
brain region is commonly implicated in geriatric depression
and MDD (Alexopoulos et al. 2008; De Asis et al. 2003).
There are several possible reasons for our null result in the
ACC. It may be that volume loss in the PCC (a region that
possesses both structural and functional connections with
the ACC) and lateral parietal lobe shown by some elders
with depression precedes ACC volume loss. Another
possibility is that our chosen measurement of depressive
symptoms—the CES-D—was not sensitive to the aspects of
depression typically associated with changes in the ACC
and adjacent medial prefrontal cortex. With a measurement
scale more sensitive to depressive symptoms such as apathy
and reduced motivation and interest—symptoms often
associated with ACC changes—we may have detected
group differences in this brain region.
Although the current findings are intriguing, conclusions
are preliminary due to limitations of our methods. We
evaluated depressive symptoms using a validated question-
naire;however,useofacomprehensivepsychiatricinterview
would have allowed better characterization of depressive
symptomatology,the extent of depressive symptoms,and the
time of onset of depressive symptoms. An analysis that
parsed items loading on previously-identified factors
revealed that our participants with depressive symptoms
endorsed mood symptoms and somatic symptoms, but few
items assessing interpersonal difficulty. However, we were
unable to make other useful distinctions (e.g., parsing
dysphoric feelings versus apathy; or parsing early versus
late-life onset). Also, because our sample was community-
based and the range of depressive symptoms was restricted
(participants reported not having a psychiatric diagnosis of
Major Depressive Disorder), our results can only be
generalized to older individuals experiencing mild to
moderate depressive symptoms. Individuals who volunteer
to participate in clinical research studies often differ from
non-volunteers in systematic ways (e.g., higher socioeco-
nomic status; Szklo and Nieto 2006); and this restricts our
ability to draw inference about the wider population. In
terms of our imaging methods, our choice to conduct a
whole-brain, voxel-wise analysis may have forestalled our
ability to detect nuanced regional brain alterations—such as
those in the hippocampus. Despite these limitations, results
of this study show that geriatric depression is associated
with decreased brain volume in regions vulnerable to AD.
This suggests that the depressed group may have early
brain changes associated with Alzheimer’s disease; howev-
er, this conclusion is preliminary given the cross-sectional
design of our study. More definitive assessment of the
hypothesis that brain changes seen in depressed older
individuals reflect early AD awaits testing in a prospective
cohort study.
Brain Imaging and Behavior (2009) 3:233–239 237A note about the multifactorial etiology of depressive
symptoms provides another caveat to interpreting the
current findings. Depressive symptoms and MDD, of
course, arise not simply from disease-related changes in
neural structure and function, but also as a response to life
transitions, disability, and loss (Alexopoulos 2005). Fur-
thermore, the relationship existing between depression and
AD-like brain changes is far from simple. Geda et al.
(2006) astutely proposed that multiple mechanisms may
underlie the association between incident MCI and depres-
sion, and similarly, multiple mechanisms may underlie the
association between observed AD-like brain changes and
depression: (1) AD-like brain changes may cause depres-
sion; (2) a separate genetic or environment factor may
cause both AD-like brain changes and depression, or (3)
brain changes associated with AD may give rise to
depression only in the presence of a mediating genetic
susceptibility or environmental factor. It is clear that early
detection of AD will be facilitated through continued
investigation of the relationship among the behavioral
manifestations of geriatric depression, the brain changes
associated with the AD pathological process, and factors
that may mediate this association.
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